A recent study published in JAMA Oncology reveals that over half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments, such as chemotherapy and immunotherapy, due to barriers like late diagnosis, access issues, shame, and fatalism, despite the availability of new drugs that have significantly improved treatment options. #LungCancer #CancerTreatment #HealthEquity #US

